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A Novel Locus for Leber Congenital Amaurosis Maps
to Chromosome 6q
To the Editor:
Leber congenital amaurosis (LCA) (MIM 204000/
204100) is a clinically and genetically heterogeneous ret-
inal disorder that occurs in infancy and is accompanied
by profound visual loss, nystagmus, poor pupillary re-
flexes, and either a normal retina or varying degrees of
atrophy and pigmentary changes (Leber 1869, 1871;
Franc¸ois 1968). The electroretinogram (ERG) is extin-
guished or severely reduced (Franceschetti 1954). LCA
is largely a recessive disease, although autosomal dom-
inant pedigrees have been identified (Sorsby et al. 1960;
Heckenlively 1988). To date, three genes for LCA have
been identified and sequenced: retinal guanylate cyclase
(GUCY2D) on chromosome 17p13; retinal pigment ep-
ithelium protein (RPE65) on chromosome 1p31; and
cone-rod homeobox (CRX) on chromosome 19q13.3.
One additional locus has been identified on chromosome
14q24 (Stockton et al. 1998). We show evidence for
linkage to chromosome 6q11-16 in a multigenerational
kindred of Old Order River Brethren. The disease gene
maps to a 23-cM interval flanked by DNA polymorphic
markers D6S1551 and D6S1694, with a maximum two-
point LOD score of 3.38 (recombination fraction [v]
zero) at D6S391. Two candidate genes on chromosome
6 were screened for mutations: gamma aminobutyric
acid rho1 and rho2 (GABRR1 and GABRR2) at 6q14-
21 (Cutting et al. 1992), and interphotoreceptor matrix
proteoglycan (IMPG1) at 6q13-15 (Gehrig et al. 1998).
The incidence of LCA is 3 in 100,000 persons and
accounts for 5% of all inherited retinal dystrophies
(Perrault et al. 1996). Clinical and genetic heterogeneity
have been demonstrated (Wardenburg 1961; Camuzat
et al. 1996). The phenotype has been associated with
familial juvenile nephronophthisis and cone-shaped
epiphyses (Saldino-Mainzer syndrome) and with kidney
disease (Senior-Loken syndrome), osteoporosis, meta-
bolic diseases, and neurological abnormalities (Loken et
al. 1961; Senior et al. 1961; Dekaban 1969; Mainzer et
al. 1970; Ellis et al. 1984).
The first locus for LCA was mapped to 17p13 with
the use of homozygosity mapping in consanguineous
families of North African descent (Camuzat et al. 1996).
Mutations in the retina-specific guanylate cyclase gene
(RETGC 1), on chromosome 17p13, involved in pho-
totransduction, were subsequently identified (Perrault et
al. 1996). Mutations in RPE65 on chromosome 1p31,
specific to the retinal pigment epithelium involved in
retinoid metabolism, were reported in patients with
LCA, thus establishing a second gene (LCA2) for this
heterogeneous disease (Marlhens et al. 1997). The pho-
toreceptor-specific homeobox gene CRX, on chromo-
some 19q13.3, has been implicated as the third gene,
since mutations were demonstrated (Freund et al. 1998).
A novel locus on chromosome 14q24 (LCA3) was iden-
tified in consanguineous Saudi Arabian families (Stock-
ton et al. 1998).
We studied a consanguineous family belonging to the
Old Order River Brethren, a religious isolate originating
in eastern Pennsylvania. The Old Order River Brethren
descended from the Swiss, who emigrated to America in
the 1750s in pursuit of religious freedom (Breckvill
1972). The kindred includes three affected individuals
in two related sibships (fig. 1) who were initially eval-
uated at the Johns Hopkins Center for Hereditary Eye
Diseases (JHCHED) and who are being followed an-
nually. The patients presented with visual acuities in the
order of 20/100–20/400, nystagmus, high hypermetro-
pia, poor pupillary reflexes, and normal fundi. Progres-
sive hypermetropia and increasing peripheral retinal
mottling, of varying degree, were noted. The ERG was
abolished. Review of other systems was unremarkable.
We report a novel locus for LCA (LCA5) in this pedigree,
on chromosome 6q11-16, by linkage analysis and ho-
mozygosity mapping.
Venous blood samples were obtained from 27 family
members of the Old Order River Brethren community
and a cheek brush sample was obtained from an infant
(individual 29). Consents were obtained in accordance
with regulations of the Johns Hopkins Medical Insti-
tutions’ Joint Committee on Clinical Investigation. DNA
was isolated from whole blood by means of the QIAamp
Blood Kit (Qiagen), according to the manufacturer’s in-
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structions. The alkali method was used to obtain DNA
from the single cheek sample.
Initially, the affected members and their first-degree
relatives were screened to exclude linkage to the regions
of the previously described genes involved in LCA on
chromosomes 1, 17, and 19. The screen was then ex-
tended, by use of the whole-genome 8A multiplex ver-
sion of markers spaced at 20 cM (Research Genetics).
A region of homozygosity was identified on chromosome
6q. Further analysis, with additional markers in all po-
tentially significant family members, was undertaken.
Marker information was obtained from the Genome
Database.
PCR-based genotyping, with fluorescent labeled
markers, was performed by means of the Applied Bios-
ystems 373 automated DNA sequencer. PCR reactions
were performed in a 9600 Perkin Elmer thermocycler,
and the PCR products were checked for amplification
with a 3% agarose gel (Saiki et al. 1988).
The amplified PCR product was genotyped by means
of the automated DNA sequencer. GENESCAN ANAL-
YSIS 2.0.0 and GENOTYPER version 1.1 software were
used, to size the PCR products and to analyze the data.
Allele sizes were scored by two independent observers.
Two-point linkage analysis was performed by use of
the MLINK option of the FASTLINK program, version
5.1 (Lathrop et al. 1984; Cottingham et al. 1993.) In
this pedigree, LCA was analyzed as an autosomal re-
cessive trait with complete penetrance, with an assumed
allele frequency of .0032. A total of 40 microsatellite
markers (Research Genetics) on chromosome 6 were an-
alyzed, to determine the minimum region containing the
new gene (Lander and Botstein 1987). Marker allele fre-
quencies were estimated by means of the Genetic Anal-
ysis System, version 2.0 (Young), and GCONVERT
(Duffy). The final LOD scores were computed by means
of the allele frequencies generated by the GCONVERT
program. Recombination frequencies for males and fe-
males were assumed to be equal. All inbreeding loops
in the family were disconnected for computational rea-
sons (Ott 1991) (fig. 1).
The GENEHUNTER program was used to perform
multipoint linkage analysis against a fixed map of 17
informative markers, with an assumed equilibrium be-
tween marker and test loci (Kruglyak et al. 1996). These
markers were selected from the original 40 microsatellite
markers because they were highly polymorphic and their
relative orders and map distances were well estimated
in public databases. The comprehensive genetic map of
the Center for Medical Genetics, Marshfield Medical Re-
search Foundation, provided the sex-averaged genetic
distances for the markers noted in figure 1. The same
map provided the order for 37 markers. The remaining
three markers were placed by means of the Genome
Location Database. Subsequently, the genetic framework
map from the Center for Medical Genetics, Marshfield
Medical Research Foundation, reduced the 37 markers
to 23, indicating that some markers occurred at identical
positions. Thus, in the analyses in which multiple mark-
ers had identical positions, the markers with reduced
information content were dropped in favor of those with
better information content.
Multipoint LOD scores were computed with the same
model described above for two-point analysis. Multi-
point nonparametric linkage (NPL) scores were also
computed with the use of only the affected individuals.
Because of the inherent limitation on pedigree size in the
GENEHUNTER program, the large pedigree was
trimmed and broken into two separate units, accounting
for some potential loss of power in the analysis. The
data were examined for regions of allelic homozygosity
in the affected individuals (Dib et al. 1996). Haplotype
analysis was used to further define the interval contain-
ing the disease locus (Lathrop et al. 1985).
The following retina-specific genes on chromosome 6
were evaluated for the presence of disease-causing mu-
tations: the GABRR1 and GABRR2 genes on chro-
mosome 6q14.1-21 (Cutting et al. 1991, 1992) and the
IMPG1 gene on chromosome 6q13-15 (Gehrig et al.
1998) (fig. 2).
GABRR1 and GABRR2 are assumed to have arisen
by gene duplication and share a 50% homology with
each other. GABA is a neuroinhibitory transmitter me-
diating fast synaptic inhibition by activating chloride
channels. GABRR1 is expressed largely in the retina;
GABRR2 is expressed primarily in the brain. GABRR1
expression in the developing retina suggests its possible
role as a candidate gene. In exons 1 and 4, polymorphic
changes were identified. This did not change in the
amino acid. These polymorphic changes were also iden-
tified in the normal population. No sequence changes
were noted in GABRR2.
IMPG1, a novel gene encoding a major proteoglycan
of the interphotoreceptor matrix, is expressed in the ret-
ina by both rods and cones and maps to 6q13-15; it was
considered a further candidate gene for LCA (Gehrig et
al. 1998). No significant changes were noted after the
17 coding exons of this gene were sequenced.
Linkage of LCA in the Old Order River Brethren was
found at chromosome 6q11-16, supported by statisti-
cally significant two-point LOD scores with maximum
LOD score (Zmax) 3.38 ( ) at D6S391 (table 1). Hap-v = 0
lotype analysis of recombination events localizes the dis-
ease locus to a region of 23 cM, flanked by D6S1551
and D6S1694, thus identifying a new locus for LCA.
Critical recombinant events were observed at marker
D6S1551 in individual 29, who is unaffected, and at
marker D6S1694 in individual 24, who is affected, de-
fining the centromeric and telomeric boundaries, re-
spectively. A common haplotype covers the region in all
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Figure 2 Results of multipoint LOD score analysis using the GENEHUNTER program. The centromere is located toward the left of the
graph. Maximum LOD scores were obtained between markers D6S391 and D6S450.
the affected individuals (fig. 1). Homozygosity of other
highly informative markers across the candidate region
was noted.
The maximum multipoint LOD score was 3.10 be-
tween D6S391 and D6S450, a 9.5-cM interval (fig. 2).
The multipoint NPL score was significant, with P !
for a 23-cM region. Sequencing of candidate genes.004
GABRR1 and GABRR2 and IMPG1 revealed poly-
morphic changes only.
LCA in the Old Order River Brethren, a highly inbred
community, maps to a 23-cM interval on chromosome
6q11-16, as defined by linkage analysis and homozy-
gosity mapping. Since this population is genetically iso-
lated, and since LCA is quite rare, we presume that a
single common ancestor was a carrier for this recessive
trait (Lander and Botstein 1987). The large size of the
region of homozygosity in the family and the history of
migration indicate the recency of the mutation in the
population (fig. 1).
LCA in this pedigree was not associated with multi-
system abnormalities. Renal function remains normal.
Neurological and hepatic function were within normal
limits. The patients are of normal stature and intelli-
gence. Neither photophobia nor photoattraction was re-
ported in infancy, although pressing on the globes (the
digito-ocular phenomenon of Franceschetti-Bamatter)
played a prominent part in childhood behavior (Fran-
ceschetti 1954). Visual dysfunction, nystagmus, and the
digito-ocular phenomenon were noticed in early infancy.
A high hyperopic refractive correction was noted in all
the patients (Wagner et al. 1985). Ophthalmoscopic ex-
amination in infancy revealed normal fundi, but in child-
hood, attenuated retinal vasculature with a varying de-
gree of pigmentary changes was noticed. Electroret-
inography showed a markedly reduced response in the
affected individuals. Vision has been stable in all affected
members of the family who have been followed clinically
at JHCHED.
Genetic studies have identified a large region on chro-
mosome 6q responsible for several retinal dystrophies
(Small et al. 1992, 1993, 1997; Stone et al. 1994; Kelsell
et al. 1995, 1998; Sauer et al. 1997; Griesinger et al.
1998; Rabb et al. 1998; Ruiz et al. 1998). LCA5 lies in
the overlapping region of autosomal recessive RP at
6cen-q16 (Ruiz et al. 1998), progressive bifocal cho-
rioretinal dystrophy (PBCRA) at 6q12-21 (Kelsell et al.
1995), North Carolina macular dystrophy at 6q14-16.2
(Small et al. 1993), Stargardt-like dominant macular de-
generation (STGD3) at 6q13 (Stone et al. 1994; Grie-
singer et al. 1998), and dominant cone-rod dystrophy
(CORD7) at 6q13-15 (Kelsell et al. 1998) (fig. 3). The
occurrence of multiple loci so closely spaced in the ge-
nome could indicate the presence of a number of retinal
genes in continuum, since the phenotype of all these
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Figure 3 Chromosome 6 ideogram, showing the location of can-
didate genes screened and retinal disease loci in the region.
Table 1
Two-Point LOD Scores for Linkage between LCA and Chromosome 6 Markers
LOD SCORE AT v =
ORDER .00 .01 .50 .10 .20 .30 .40 vmax Zmax
D6S257 1.33 .17 .67 .92 .93 .71 .39 .145 .97
D6S1628 1.24 1.00 1.49 1.52 1.29 .93 .49 .084 1.53
D6S1658 1.23 .63 .15 .04 .19 .18 .11 .239 .20
D6S430 1.17 1.41 1.85 1.82 1.46 1.00 .51 .066 1.86
D6S1551 1.32 .27 .82 .94 .88 .67 .37 .117 .95
D6S1619 1.20 1.17 1.03 .87 .59 .36 .17 .001 1.20
D6S1596 1.23 1.20 1.10 .96 .71 .47 .23 .001 1.23
D6S391 3.38 3.30 3.00 2.62 1.87 1.16 .55 .001 3.38
D6S1707 3.15 3.07 2.76 2.37 1.63 .98 .47 .001 3.15
D6S251 3.22 3.14 2.83 2.45 1.71 1.06 .50 .001 3.22
D6S445 2.97 2.89 2.59 2.23 1.56 .98 .48 .001 2.97
D6S1627 2.33 2.28 2.07 1.82 1.33 .87 .43 .001 2.33
D6S1644 2.20 2.15 1.93 1.66 1.17 .74 .35 .001 2.20
D6S1631 2.70 2.63 2.38 2.07 1.47 .93 .45 .001 2.70
D6S450 2.28 2.23 2.01 1.74 1.24 .79 .38 .001 2.28
D6S1056 1.47 1.42 1.22 1.02 .70 .46 .23 .001 1.47
D6S300 1.24 1.33 1.43 1.36 1.07 .71 .35 .050 1.43
D6S1716 .08 .10 .13 .14 .13 .11 .08 .090 .14
D6S1694 .40 .31 .14 .07 .07 .07 .04 .848 .19
D6S1717 .73 .74 .77 .77 .65 .43 .20 .827 .39
D6S261 1.18 .60 .10 .10 .23 .21 .13 .231 .23
retinal dystrophies, their ophthalmologic appearance,
age at onset, and the extent and pattern of visual loss
are varied. On the other hand, like the ABCR gene mu-
tations that cause autosomal recessive retinitis pigmen-
tosa (Martinez-Mir et al. 1997, 1998), juvenile and late-
onset fundus flavimaculatus (Allikmets et al. 1997a),
cone-rod dystrophy (Cremers et al. 1998), age-related
macular disease, and recessive Stargardt disease (Kaplan
et al. 1993; Gerber et al. 1995, 1998; Allikmets et al.
1997b), leading to distinct phenotypes (Lewis et al.
1999), it is possible that a single large gene in the prox-
imal centromeric portion of the long arm of chromosome
6 could cause a myriad of retinal dystrophies, LCA being
the most severe.
Perhaps LCA5 is allelic with STGD3, RP25, CORD7,
MCDR, and PBCRA. It is conceivable that mutations
in different sites cause different structural alterations in
the predicted protein, predisposing to varying pheno-
types (Rozet et al. 1998).
The three other genes causing LCA are known to cause
other phenotypically varied retinal dystrophies as well,
raising the possibility of a similar situation in the LCA5
gene. GUCY2D mutations (LCA1) have been identified
in autosomal dominant cone-rod dystrophy (Kelsell et
al. 1998), although RPE65 (LCA2) mutations cause au-
tosomal recessive retinitis pigmentosa as well as LCA
(Morimura et al. 1998). Mutations in the cone-rod hom-
eobox gene are now known to cause autosomal domi-
nant cone-rod dystrophy, LCA, and late-onset dominant
retinitis pigmentosa (Sohocki et al. 1998). It is currently
possible to identify mutations of the known LCA genes
in less than one-third of the patients with LCA (Dhar-
maraj et al. 1999). The isolation of another locus for
this retinal disorder, LCA5, on chromosome 6q, will
account for an additional proportion of patients with
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an identifiable gene mutation. Recruitment of additional
families with LCA to further narrow the critical region
is under way, and candidate gene analysis continues.
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A Gene for an Autosomal Dominant Scleroatrophic
Syndrome Predisposing to Skin Cancer (Huriez
Syndrome) Maps to Chromosome 4q23
To the Editor:
Huriez syndrome (MIM 181600), also referred to as
“sclerotylosis,” is an autosomal dominant genoderma-
tosis, characterized by the triad of congenital scleroa-
trophy of the distal extremities, palmoplantar kerato-
derma (PPK), and hypoplastic nail changes, that was first
described in two large pedigrees from northern France
(Huriez et al. 1968). Several additional families have
since been described ( Lambert et al. 1977; Fischer 1978;
Shaw et al. 1978; Hamm et al. 1996; Kavanagh et al.
1997). The development of aggressive squamous cell car-
cinoma (SCC) of the affected skin is a distinctive feature
of the syndrome, occurring in ∼15% of affected indi-
viduals. SCC in Huriez syndrome is characterized by
early onset, mostly in the third to fourth decade of life,
and by early metastasis formation (Hamm et al. 1996).
The pathogenetic mechanism of tumorigenesis in Huriez
syndrome is unknown.
Linkage to the MN–blood-type locus on chromosome
4q28-q31 was reported initially and has subsequently
been refuted (Delaporte et al. 1995; Kavanagh et al.
1997). We therefore embarked on a linkage analysis for
Huriez syndrome with highly polymorphic microsatellite
markers, beginning on chromosome 4. After informed
consent was obtained, 22 affected and 35 unaffected
members of one of the families first described by Huriez
(family A) and a second family originating from the same
region of northern France (family B) were included in
the analysis. We calculated two-point LOD scores be-
tween each marker locus and Huriez syndrome, under
the assumption of autosomal dominant inheritance with
complete penetrance, a frequency of .0005 for the dis-
ease allele, and equal allele frequencies for each marker
allele, using the LINKAGE version 5.21 software (La-
throp et al. 1984). With reference to the Human Gene
Map (Schuler et al. 1996), we identified marker D4S424
within 2 cM of the glycophorin A gene (GYPA), which
is the erythrocyte membrane protein that encodes the
MN–blood-group receptors. D4S424 yielded a LOD
score of 10.7 at recombination fraction (v) 0.01. In
the families under investigation, the MN–blood-type lo-
cus was therefore excluded as a candidate region for
Huriez syndrome. Our finding is consistent with the ex-
clusion of the MN locus in the first English family with
Huriez syndrome (Kavanagh et al. 1997). In contrast,
marker D4S1560 gave evidence for linkage, with a LOD
score of 4.4 at . Subsequent analysis of additionalv = 0
flanking markers confirmed localization of the Huriez
locus to this region, with the highest LOD score (Zmax)
of 12.22 at , with D4S2380 (table 1). For fine map-v = 0
ping of the candidate region, additional microsatellite
markers were selected and mapped on the high-resolu-
tion Stanford Human Genome Center TNG radiation
hybrid panel. Relative distances in centirays (fig. 1) were
determined with reference to the Stanford G3 panel
(Stewart et al. 1997).
Under the more conservative assumption of incom-
plete penetrance, the candidate interval is defined by two
recombination events in one affected individual (family
A, member 6.1). Here, the 17-cM region is delimited
centromerically by D4S395 and distally by D4S411.
Under the assumption of complete penetrance, two ad-
ditional recombination events in two unaffected pro-
bands further limit the Huriez locus (fig. 2): one in family
A (member 4.11), localizing the gene telomeric to
D4S1544, and the other in family B (member 2.5), lo-
calizing the gene centromeric to D4S2966. The Huriez
locus is thus confined to an 8-cM region between
D4S1544 and D4S2966. Haplotypes were constructed
for both families by use of 16 markers between D4S2963
and D4S1564. Comparison between the disease alleles
of the two families revealed three adjacent markers iden-
tical by state (IBS) (fig. 1). For two of these markers,
D4S2973 and D4S1559, the shared allele is the most
common allele found among all individuals, with relative
frequencies of .87 and .58, respectively. There is no
known relationship between the two families investi-
gated. However, in view of the rarity of the condition
